Show simple item record

Leveraging epitranscriptomics for cardiovascular disease theranostics

dc.creatorSopić, Miron
dc.creatorStopa, Victoria
dc.creatorDevaux, Yvan
dc.date.accessioned2024-01-15T17:19:32Z
dc.date.available2024-01-15T17:19:32Z
dc.date.issued2024
dc.identifier.issn1522-9645
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5432
dc.language.isoensr
dc.publisherOxford University Press on behalf of the European Society of Cardiologysr
dc.relationThe Horizon Europe (HORIZON-MSCA-2021-PF- MAACS 101064175)sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//sr
dc.relationThe Heart Foundation—Daniel Wagner. Y.D. is funded by the EU Horizon 2020 project COVIRNA (grant agreement # 101016072)sr
dc.relationThe National Research Fund (grants # C14/BM/8225223, C17/BM/ 11613033 and COVID-19/2020-1/14719577/miRCOVID)sr
dc.relationThe Ministry of Higher Education and Research, and the Heart Foundation-Daniel Wagner of Luxembourgsr
dc.rightsrestrictedAccesssr
dc.sourceEuropean Heart Journalsr
dc.titleLeveraging epitranscriptomics for cardiovascular disease theranosticssr
dc.typearticlesr
dc.rights.licenseARRsr
dc.citation.volume45
dc.citation.issue13
dc.citation.spage1098
dc.citation.epage1100
dc.citation.rankaM21~
dc.identifier.wos001143091300001
dc.identifier.doi10.1093/eurheartj/ehad852
dc.identifier.pmid38190430
dc.identifier.scopus2-s2.0-85189454667
dc.type.versionpublishedVersionsr


Files in this item

Thumbnail
Name:
Leveraging_epitranscriptomics_ ...
Size:
218.9Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record